Refine
Year of publication
Document Type
- Article (819)
- Preprint (717)
- Conference Proceeding (7)
- Part of Periodical (4)
- Working Paper (3)
- Book (2)
- Course Material (1)
Has Fulltext
- yes (1553)
Is part of the Bibliography
- no (1553)
Keywords
- Heavy Ion Experiments (21)
- breast cancer (13)
- Mammakarzinom (12)
- glioblastoma (12)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Behandlung (8)
- Metastasen (8)
- CDK4/6 (6)
- Heavy-ion collision (6)
- PD1/PDL1 (6)
- Prävention (6)
- Studien (6)
- prevention (6)
- schizophrenia (6)
- treatment (6)
- MRI (5)
- metastases (5)
- risk (5)
- ALICE experiment (4)
- Collective Flow (4)
- Glioblastoma (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- Risiko (4)
- glioma (4)
- hypoxia (4)
- immunotherapy (4)
- trials (4)
- ALICE (3)
- Breast cancer (3)
- EGFR (3)
- Elastic scattering (3)
- Heavy Ions (3)
- Heavy Quark Production (3)
- Jets and Jet Substructure (3)
- PDGFRβ (3)
- Relativistic heavy-ion collisions (3)
- bevacizumab (3)
- biomarker (3)
- chemotherapy (3)
- chimeric antigen receptor (3)
- cirrhosis (3)
- cytokine-induced killer cells (3)
- global change (3)
- meningioma (3)
- metastatic (3)
- neoadjuvant therapy (3)
- pp collisions (3)
- stroke (3)
- targeted therapy (3)
- Alpelisib (2)
- Atezolizumab (2)
- Beauty production (2)
- CIK cells (2)
- COPD (2)
- COVID-19 (2)
- CRM (2)
- Charm physics (2)
- Critical care (2)
- Diagnostik (2)
- Diffraction (2)
- Drug therapy (2)
- Elliptic flow (2)
- Epilepsy (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Extended donor criteria (2)
- Fasting (2)
- Früherkennung (2)
- Galaktografie (2)
- Galaktomosynthese (2)
- Genetics (2)
- Genetics research (2)
- Glucose (2)
- HER2/neu (2)
- Heavy-ion collisions (2)
- IDH mutation (2)
- Immunology (2)
- KGF (2)
- Katherine (2)
- Ketogenic diet (2)
- Leptin (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Lokalrezidiv (2)
- MEG (2)
- MRT (2)
- Machine learning (2)
- Malaria (2)
- Mamma (2)
- NK-92 (2)
- Nachsorge (2)
- PARP (2)
- PD-1 (2)
- PD-L1 (2)
- PD1/ PDL1 (2)
- PD‑L1 (2)
- PI3K (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Peritonitis (2)
- Personalized medicine (2)
- Polarization (2)
- Predictive markers (2)
- Prognosefaktoren (2)
- Prädiktivfaktoren (2)
- Psychiatric disorders (2)
- Pulmonary embolism (2)
- QCD (2)
- Quarkonium (2)
- RHIC (2)
- ROS (2)
- Radiation (2)
- Radiotherapy (2)
- Richtlinie (2)
- Sestrin 2 (2)
- Single electrons (2)
- Supportivtherapie (2)
- Surgery (2)
- Targeted therapy (2)
- Temozolomide (2)
- Tomosynthese (2)
- T‑DM1 (2)
- Ultraschall (2)
- adjuvant therapy (2)
- adjuvante Therapie (2)
- adult (2)
- advanced (2)
- allogeneic stem cell transplantation (2)
- alpelisib (2)
- anaemia (2)
- anti-angiogenic therapy (2)
- atezolizumab (2)
- biodiversity protection (2)
- brain metastases (2)
- brain metastasis (2)
- breast (2)
- composite structures (2)
- conservation funding (2)
- conservation planning (2)
- decision making (2)
- diagnosis (2)
- early breast cancer (2)
- follow‑up (2)
- fortgeschritten (2)
- frühes Mammakarzinom (2)
- galactography (2)
- galactomosynthesis (2)
- genome (2)
- guideline (2)
- local recurrence (2)
- mTOR (2)
- mitochondria (2)
- neoadjuvante Therapie (2)
- neural oscillations (2)
- post-2020 biodiversity targets (2)
- predictive factors (2)
- prognostic factors (2)
- screening (2)
- starvation (2)
- strategic site selection (2)
- studies (2)
- supportive therapy (2)
- tomosynthesis (2)
- treatment/therapy (2)
- tumor microenvironment (2)
- ultrasound (2)
- 140Ce (1)
- 19F MR spectroscopy (1)
- 1H MR spectroscopy (1)
- 2-deoxyglucose (2-DG) (1)
- 2-hydroxyglutarate (1)
- 4-1BB (1)
- 900 GeV (1)
- AB-serum (1)
- ABC transporters (1)
- ALICE detector (1)
- AML (1)
- APP processing (1)
- APRI (1)
- ARDS (1)
- ATPases (1)
- Active middle ear implants (1)
- Acute cough (1)
- Acute myeloid leukemia (1)
- Addison’s disease (1)
- Advanced biliary tract cancer (1)
- Advanced breast cancer (1)
- Adverse events (1)
- Aiolochroia crassa (1)
- Alien (1)
- All-trans retinoic acid (1)
- Allogeneic hematopoietic stem (1)
- Alzheimer (1)
- Ambroxol (1)
- Aneurysmal subarachnoid hemorrhage (1)
- Angiogenesis (1)
- Anti-nuclei (1)
- Antihormone therapy (1)
- Appendectomy (1)
- Appendicitis (1)
- Artemether-lumefantrine (1)
- Artemisinin-combination-therapy (1)
- Artenschutz (1)
- Artesunate (1)
- Artificial Intelligence (1)
- Asset Purchase Programme (1)
- Astrocytoma (1)
- Auditory system (1)
- B cell malignancies (1)
- B-slope (1)
- BEACOPP (1)
- BRAF (1)
- BRAF V600E (1)
- BTC (1)
- Baryonic resonances (1)
- Bevacizumab (1)
- Big Data (1)
- Biodiversity (1)
- Biodiversity Data (1)
- Biodiversität (1)
- Biogeographical representativeness (1)
- Bioinformatics (1)
- Biological (1)
- Biomarker (1)
- Biomarkers (1)
- Biomonitoring (1)
- Biotopschutz (1)
- Bipolar disorder (1)
- Blood-brain barrier (1)
- Bone conduction devices (1)
- Bone metastases (1)
- Boosted Jets (1)
- Botanical Collections (1)
- Brain metastasis (1)
- Brain tumor (1)
- Burkholderia arboris (1)
- Business strategy in drug development (1)
- C5 acylcarnitine (1)
- CAR (1)
- CD137 (1)
- CD3/CD19 depletion (1)
- CD74 (1)
- CDI (1)
- CDK4/CDK6 (1)
- COVID (1)
- CTLA-4 (1)
- CVD biomarker (1)
- CVID (1)
- CYP450 (1)
- Cancer (1)
- Cancer genomics (1)
- Candida (1)
- Cardiomyocyte signaling pathways (1)
- Cardioprotection (1)
- Cardiovascular disease (1)
- Cell biology (1)
- Cell membranes (1)
- Central Bank Communication (1)
- Central nervous system metastases (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charge fluctuations (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Charmonia (1)
- Cherenkov counter: lead-glass (1)
- Chimerism (1)
- Circadian (1)
- Cleanliness level (1)
- Clinical genetics (1)
- Clinical study (1)
- Closure (1)
- Coalescence (1)
- Cold nuclear matter effects (1)
- Collective Flow, (1)
- Collectivity (1)
- Colon capsule endoscopy (1)
- Comorbidities (1)
- Comparison with QCD (1)
- Complementation rate (1)
- Complicated appendicitis (1)
- Consensus statement (1)
- Conservation (1)
- Coronary heart disease (1)
- Correlation (1)
- Covid19-nmr (1)
- Critical point (1)
- Cytoskeleton (1)
- DDIT4 (1)
- DEE (1)
- DNA methylation (1)
- DST (1)
- Data management (1)
- Data sharing (1)
- Decision trees (1)
- Depression (1)
- Deuteron production (1)
- Dexamethasone (1)
- Di-hadron correlations (1)
- Diagnostic differentiation (1)
- Diagnostic markers (1)
- Diesel (1)
- Digitization (1)
- Direct oral anticoagulation (1)
- Drug susceptibility testing (1)
- Drug targeting (1)
- E/I-Balance (1)
- EBV (1)
- EET (1)
- EGFR inhibitor (1)
- EGFRvIII mutation (1)
- EMT (1)
- ERBB2 (1)
- ERBB2 (HER2/neu) (1)
- Ecosystem integrity (1)
- Ecosystems (1)
- Edema (1)
- Edition (1)
- Electromagnetic transitions (1)
- Electron-pion identification (1)
- Electronic properties and materials (1)
- Electrophysiology (1)
- Electroweak interaction (1)
- Emotions (1)
- Endothelial permeability (1)
- Entomology (1)
- Environment (1)
- Epidemiology (1)
- Epidermal growth factor receptor (1)
- Epstein-Barr virus (1)
- Essential biodiversity variables (1)
- Europe (1)
- European Society for Immunodeficiencies (ESID) (1)
- Ewing sarcoma (1)
- Exosomes (1)
- Extended Glasgow outcome scale (eGOS) (1)
- Extracellular RNA (eRNA) (1)
- FFPE (1)
- FIB-4 (1)
- Falciparum (1)
- Fc receptor (1)
- Femtoscopy (1)
- Ferroelectrics and multiferroics (1)
- Fibre/foam sandwich radiator (1)
- Fibrosis (1)
- Filgrastim (1)
- First site of metastatic disease (1)
- Fistula (1)
- Flow (1)
- Forward Guidance (1)
- Frankfurt am Main (1)
- Freezeout (1)
- Gadobutrol (1)
- Gadopentate dimeglumine (1)
- Gamma-Band Activity (1)
- Gene regulation (1)
- German PID-NET registry (1)
- Glioblastoma survival (1)
- Glioma (1)
- Grading (1)
- Graft function (1)
- Graft survival (1)
- Groomed jet radius (1)
- Guanine nucleotide exchange factors (1)
- Guanosine triphosphatase (1)
- Guided waves (1)
- Guidelines (1)
- HADES (1)
- HBT (1)
- HBV (1)
- HER2 c-erbB2 (1)
- HER2-positive (1)
- HIPPO signalling (1)
- HLA class II (1)
- HLA peptidome (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hadronization (1)
- Hand-foot syndrome (1)
- Hard Scattering (1)
- Head and neck cancer (1)
- Health policy (1)
- Healthy stem cell donors (1)
- Heart regeneration (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ion collisions (1)
- Heavy ions (1)
- Heavy-Ion Collision (1)
- Heavy-flavor decay electron (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion (1)
- Heavy-ion reactions (1)
- Hepatitis C virus (1)
- Herbaria (1)
- Heregulin (1)
- Hif-1 alpha (1)
- Hif1α (1)
- Higher moments (1)
- Hippocampus (1)
- Human behaviour (1)
- Hyperons (1)
- IDH1 inhibitor (1)
- IL-15 (1)
- IL-21 (1)
- IVA interference tandem mass spectrometry (1)
- IgG substitution therapy (1)
- IgGAM (1)
- Immunogenetics (1)
- Immunomodulatory agents (1)
- Inclusive spectra (1)
- Incomplete colonoscopy (1)
- Induced pluripotent stem cells (1)
- Induction chemotherapy (1)
- Influenza (1)
- Intensity interferometry (1)
- Interference fragmentation function (1)
- Intra-abdominal infection (1)
- Invariant Mass Distribution (1)
- Inverse kinematics (1)
- Ionisation energy loss (1)
- Ischemia–reperfusion injury (1)
- Isoflurane (1)
- Isoscalar giant resonances (1)
- Isoxazoline Alkaloids (1)
- J/ψ suppression (1)
- Jet Physics (1)
- Jet Substructure (1)
- Jet substructure (1)
- KCGS (1)
- KPS (1)
- Kreuzenzian (1)
- Kreuzenzian-Ameisenbläuling (1)
- LC3B (1)
- LTER (1)
- Laparoscopic appendectomy (1)
- Laparostomy (1)
- Laubmoss (1)
- Lebermoos (1)
- Lesion (1)
- Library screening (1)
- Lipid metabolism (1)
- Liver transplantation (1)
- London (1)
- Long term output (1)
- Long-term ecological monitoring (1)
- Long‐term ecosystem research (1)
- Low grade glioma (1)
- Low volume prep (1)
- Low-molecular-weight heparin (1)
- Luciferase (1)
- Lung cancer (1)
- Lymphocytes (1)
- Lymphoid tissues (1)
- M. Intracellulare (1)
- M. avium (1)
- M. avium complex (1)
- M. chimaera (1)
- MACS (1)
- MET (1)
- MGMT (1)
- MGMT promoter (1)
- MM-121 (1)
- MRI patterns of gliomas (1)
- Magnetic properties and materials (1)
- Magnetic resonance imaging (MRI) (1)
- Malariae (1)
- Malignant meningioma (1)
- Mammalian target of rapamycin (1)
- Marginal grafts (1)
- Material budget (1)
- Materials science (1)
- Medical imaging (1)
- Meningioma (1)
- Mental health and psychiatry (1)
- Mesh (1)
- Meta-analysis (1)
- Metabolism (1)
- Metastatic (1)
- MicroRNAs (1)
- MicroRNAs (miRNAs) (1)
- Mid-rapidity (1)
- Minimal residual disease (1)
- Minimum Bias (1)
- Mitochondria (1)
- Mixed hearing loss (1)
- Models & methods for nuclear reactions (1)
- Molecular biology (1)
- Molecular matched therapy (1)
- Molecular neuroscience (1)
- Molecular profiling (1)
- Molecular subtypes (1)
- Monte Carlo (1)
- Moviprep (1)
- Multi-Parton Interactions (1)
- Multi-stakeholder approach (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multiomics (1)
- Multiple parton interactions (1)
- Multivariate analysis (1)
- N-methyl-D-aspartate receptor (1)
- NADPH oxidase (1)
- NK cells (1)
- NMR spectroscopy (1)
- NSAIDs (1)
- NSCLC (1)
- NTM (1)
- Nanoscale materials (1)
- Neoadjuvant therapy (1)
- Neolithic (1)
- Net-charge correlations (1)
- Net-charge fluctuations (1)
- Network analysis (1)
- Neural network (1)
- Neuropilin (1)
- Neuroscience (1)
- Neutron physics (1)
- Nimotuzumab (1)
- Non-falciparum (1)
- Non-interventional study (1)
- Non-trauma (1)
- Non-tuberculous mycobacteria (1)
- Nonflow (1)
- Noninferiority (1)
- Nox1 (1)
- NoxO1 (1)
- Nuclear Physics (1)
- Nuclear modification factor (1)
- Nuclear reactions (1)
- Nucleophosmin-1 (1)
- Nucleus (1)
- Nutrition (1)
- Obesity (1)
- Observation (1)
- Oligodendroglioma (1)
- Omics (1)
- Oncology (1)
- Open abdomen (1)
- Organ allocation (1)
- Organ rinse (1)
- Organ shortage (1)
- Osteoporosis (1)
- Outcome (1)
- Ovale (1)
- PID prevalence (1)
- PML (1)
- PTEN (1)
- PXA (1)
- PYTHIA (1)
- Paediatrics (1)
- Pancreas transplantation (1)
- Pancreatitis (1)
- Parainfluenza (1)
- Particle and Resonance Production (1)
- Pathological complete response (1)
- Pathology (1)
- Patterns of care (1)
- Pb–Pb (1)
- Pentaglobin (1)
- Pharmacy setting (1)
- Phase transitions and critical phenomena (1)
- Phospho-soda (1)
- Phosphorylation (1)
- Phylogenomics (1)
- Physical and mental health (1)
- Physiology (1)
- PillCamColon2 (1)
- Plasmodium (1)
- Pneumonia (1)
- Polyps (1)
- Population genetics (1)
- Pre-emptive immunotherapy (1)
- Predictive medicine (1)
- Production Cross Section (1)
- Prognostic models (1)
- Properties of Hadrons (1)
- Prostate cancer (1)
- Proton (1)
- Proton-proton collisions (1)
- Proton–proton (1)
- Proton–proton collisions (1)
- Pseudomonas aeruginosa (1)
- Psychiatry (1)
- Psychometrics (1)
- Pulmonary edema (1)
- Pyogenic spondylodiscitis (1)
- QGP (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Questionnaires (1)
- Quinine (1)
- RMS (1)
- RNA (1)
- RNA PT (1)
- RNA modification (1)
- Radiation necrosis (1)
- Radiative capture (1)
- Rapidity Range (1)
- Re-exploration (1)
- Reactive oxygen species (1)
- Red blood cell transfusion (1)
- Regression analysis (1)
- Rehabilitation (1)
- Reigen (1)
- Reintervention (1)
- Rejection (1)
- Relativistic heavy ion physics (1)
- Remote ischemic conditioning (1)
- Renal lesions (1)
- Research Article (1)
- Research Infrastructure (1)
- Research infrastructure (1)
- Resolution Parameter (1)
- Resonance reactions (1)
- Respiratory distress syndrome (1)
- Respiratory syncytial virus (1)
- Rheumatoid arthritis (1)
- Rheumatology (1)
- Risk factor (1)
- SARS-CoV-2 (1)
- SF-12 (1)
- SKALE score (1)
- SNP (1)
- STAMPE2 (1)
- STAR (1)
- SWATH (1)
- Salivary gland carcinoma (1)
- Schizophrenia (1)
- Schnitzler, Arthur (1)
- Seasonal variation (1)
- Semantics (1)
- Sepsis (1)
- Seribantumab (1)
- Severe bacterial infection (1)
- Severe malaria (1)
- Shear viscosity (1)
- Side effect (1)
- Single muons (1)
- Site networks (1)
- Small molecules (1)
- Socio-ecology (1)
- SoftDrop (1)
- Solar insolation (1)
- Sorafenib (1)
- Sozialpsychiatrischer Dienst (1)
- Spin alignment (1)
- Splitting function (1)
- Sponges (1)
- Stadtentwicklung (1)
- Stadtökonomie (1)
- Status epilepticus (1)
- Stem-cell therapies (1)
- Stentoplasty (1)
- Storage ring (1)
- Strangeness (1)
- Structure Elucidation (1)
- Suicide (1)
- Sunlight (1)
- Superinfection (1)
- Superoxide (1)
- Surgical oncology (1)
- Synaptic plasticity (1)
- Synthetic (1)
- Systematic Uncertainty (1)
- T-DM1 (1)
- TGF-β (1)
- TGFB-induced factor homeobox 1 (1)
- TGIF (1)
- TIRADS (1)
- TOR signalling (1)
- TR (1)
- TRPA1 (1)
- TTW nodules (1)
- Tacrolimus (1)
- Tailored medicine (1)
- Taxonomy (1)
- Technical data (1)
- Technique (1)
- Tet-inducible system (1)
- Therapeutic anticoagulation (1)
- Therapies (1)
- Thermal model (1)
- Time Projection Chamber (1)
- Timing (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Transversity (1)
- Trauma (1)
- Treatment outcome (1)
- Trigger (1)
- Triple negative (1)
- Tumor heterogeneity (1)
- Tumor infiltrating lymphocytes (1)
- Uncomplicated appendicitis (1)
- Unconventional Monetary Policy (1)
- Upper respiratory tract infection (1)
- VEGF (1)
- VEGF receptors (1)
- VEGFR (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- Vascular emergencies (1)
- Vector Boson Production (1)
- Versorgungsstrukturen (1)
- Vertebral augmentation (1)
- Vertebral body stenting (1)
- Vertebral fracture (1)
- Vesicles (1)
- Viral load (1)
- Warburg effect (1)
- Weltstadt (1)
- WoMo score (1)
- X-ray crystallography (1)
- Xenon-based gas mixture (1)
- Zuckerkandl’s tubercle (1)
- Zwangseinweisungen (1)
- accident (1)
- acneiform skin toxicity (1)
- acoustic radiation force impulse imaging (1)
- acute coronary syndromes (1)
- acute‐on‐chronic liver failure (1)
- adjuvant chemotherapy (1)
- adoptive cancer immunotherapy (1)
- adrenal insuffciency (1)
- advanced breast cancer (1)
- advanced melanoma (1)
- agaricomycetes (1)
- age (1)
- age-related macular degeneration (1)
- alirocumab (1)
- alleles (1)
- amphiregulin (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- angiogenesis (1)
- angiopoietin-2 (1)
- antibiotic (1)
- anticonvulsants (1)
- antifungal agents (1)
- antifungals (1)
- antihormone therapy (1)
- antiviral therapy (1)
- apoptosis (1)
- aridity (1)
- astrocytoma (1)
- autism spectrum disorder (1)
- autistic disorder (1)
- autophagy (1)
- axions (1)
- biogeographic legaciese (1)
- biologicals (1)
- biomarkers (1)
- biosecurity (1)
- bone marrow metastasis (1)
- bone metastasis (1)
- bronchial epithelium (1)
- burkholderia (1)
- burkholderia cepacia complex infections (1)
- c-kit (1)
- calorimeter: electromagnetic (1)
- cancer immunotherapy (1)
- capture (1)
- cell therapy (1)
- cell transplantation (1)
- cellular therapy (1)
- cerebral pseudoprogression (1)
- cerebral radiation necrosis (1)
- cerebrospinal fluid (1)
- cerium (1)
- cetuximab-bevacizumab therapy sequence (1)
- chemogenomic set (1)
- children and adolescents (1)
- chronic viral hepatitis (1)
- circulation (1)
- climate gradient (1)
- clinical trial (1)
- clonal transfer (1)
- co-infection (1)
- colon carcinoma (1)
- complementary psychosocial care (1)
- complete response (1)
- concept (1)
- conservation (1)
- continuum model (1)
- copy number polymorphism (1)
- cross-section (1)
- cryo-EM (1)
- cryopreservation (1)
- cystic fibrosis (1)
- cytotoxic T cells (1)
- dE/dx (1)
- dabrafenib (1)
- dark matter experiments (1)
- dental implants (1)
- detector (1)
- dexamethasone (1)
- diffusion-weighted magnetic resonance imaging (1)
- digestion artifact (1)
- discomfort/pain (1)
- discontinuation (1)
- disease outbreaks (1)
- disease prevalence (1)
- disease progression (1)
- domestication (1)
- doxycycline (1)
- drug discovery (1)
- druggable genome (1)
- early childhood (1)
- ectosomes (1)
- elderly (1)
- elderly patients (1)
- electronics: readout (1)
- electrophoresis (1)
- emergency care (1)
- endemisch (1)
- epidermal growth factor receptor (1)
- epilepsy (1)
- epiregulin (1)
- everolimus (1)
- evolution (1)
- ex vivo expansion (1)
- exosomes (1)
- exotic (1)
- experimental results (1)
- expertise (1)
- extracellular vesicles (1)
- familial amyloid nephropathy with urticaria and deafness (1)
- fibre: optical (1)
- fibrotest (1)
- focused electron beam induced deposition (1)
- forest classification (1)
- forest functional similarity (1)
- fragment screening (1)
- fresh frozen plasma (1)
- freshwater ecosystems (1)
- functional connectivity (1)
- fungal infection (1)
- galunisertib monohydrate (LY2157299) (1)
- gamma (1)
- gel (1)
- gene flow (1)
- genes (1)
- genetics (1)
- genotype (1)
- genotype determination (1)
- geriatric medicine (1)
- germ cell tumors (1)
- glioblastoma survival (1)
- glioma microenvironment (1)
- gliomas (1)
- gliomatosis cerebri growth pattern (1)
- glycolysis (1)
- guidelines (1)
- habitat destruction (1)
- heavy ion experiments (1)
- hemodynamic (1)
- hepatitis c (1)
- high-dose chemotherapy (1)
- histology (1)
- histopathological growth pattern (1)
- human (1)
- hydrocephalus (1)
- hyperalgesia (1)
- hypoxia-induced cell death (1)
- immune checkpoint blockade (1)
- immune checkpoint inhibitors (1)
- immune checkpoint inhibitors (ICI) (1)
- immune infiltration (1)
- immune related adverse events (irAE) (1)
- immune response (1)
- impact (1)
- inducible gene expression (1)
- infections (1)
- infiltration (1)
- inflammation (1)
- injury (1)
- insect abundance (1)
- inter-individual variability (1)
- interim positron emissiontomography (1)
- intraventricular chemotherapy (1)
- invasion (1)
- invasive growth (1)
- investigational (1)
- involuntary hospitalization (1)
- isocaloric ketogenic diet (1)
- isovaleric acidaemia (1)
- kidney function (1)
- kinase inhibitor (1)
- land use (1)
- lapatinib (1)
- leptomeningeal disease (1)
- leptomeningeal metastases (1)
- leukopenia (1)
- liver metastasis (1)
- lockdown (1)
- long-term protection (1)
- long-term research (1)
- long36 term protection (1)
- low-density lipoprotein cholesterol (1)
- lymphoma (1)
- mTOR inhibition (1)
- magentoencephalography (MEG) (1)
- magnetic resonance imaging (1)
- magnetoencephalography (1)
- major adverse cardiovascular events (1)
- malignant glioma (1)
- management (1)
- marked lymph node (1)
- mass spectrometry (1)
- medical device (1)
- medulloblastoma (1)
- melanoma (1)
- membrane proteins (1)
- mental health services (1)
- mentalizing (1)
- metabolic cancer therapy (1)
- metabolism (1)
- metastasis (1)
- metastatic renal cell carcinoma (1)
- microbial colonization (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- moisturing cream (1)
- molecular machines (1)
- mouthwash (1)
- mouthwash solution (1)
- multifocal (1)
- multiplexed immunofluorescence (1)
- murine model (1)
- n_TOF (1)
- native (1)
- natural killer cells (1)
- neoadjuvant chemoradiotherapy (1)
- neoadjuvant immunochemotherapy (1)
- neuroblastoma (1)
- neurodegeneration (1)
- neuroimaging (1)
- neurological complication (1)
- neurological side effects (1)
- neutron (1)
- neutropenia (1)
- nitrogen (1)
- nivolumab (1)
- nociceptors (1)
- nodular lymphocyte-predominant Hodgkin lymphoma (1)
- non-invasive fibrosis assessment (1)
- nonnative (1)
- nuclear receptor (1)
- nucleoside analysis (1)
- nucleosynthesis (1)
- nutrient availability (1)
- omega stringer (1)
- open guided waves (1)
- oral cavity cancer (1)
- oscillation (1)
- outbreak (1)
- ovary (1)
- p+p collisions (1)
- p47phox (1)
- pSMAD2 (1)
- patterns of progression (1)
- pediatric cancer (1)
- pediatric intensive care (1)
- pembrolizumab (1)
- perception (1)
- perceptual closure (1)
- perceptual organization (1)
- pericytes (1)
- periodontal probing, (1)
- perioperative ischemia (1)
- peritumoral edema (1)
- peritumoral edema zone (1)
- peri‐implant probing (1)
- pertuzumab (1)
- phase IV (1)
- phenotype (1)
- phenotypic screening (1)
- phosphorus (1)
- phylogenetic community distance (1)
- phylogeny (1)
- phytometer (1)
- pivalate (1)
- pivoloyl (1)
- plant productivity (1)
- platelet lysate (1)
- platform switching (1)
- pleomorphic xanthoastrocytoma (1)
- point shear wave elastography (1)
- pole concept of goiter growth (1)
- polyacetylenes (1)
- polyines (1)
- polymorphism (1)
- polyynes (1)
- portal hypertension (1)
- post-transplantation lymphoproliferative disease (1)
- posterior horn (1)
- posteroinferior horn (1)
- precision weighting (1)
- precursor residence time (1)
- predictive biomarker (1)
- predictive biomarkers (1)
- predictive coding (1)
- pressure cycling technology (1)
- primary active transporters (1)
- primary brain tumors (1)
- primary immunodeficiency (PID) (1)
- prognosis (1)
- prophylaxis (1)
- proprotein convertase subtilisin/kexin type 9 inhibition (1)
- prosocial behavior (1)
- protein kinase (1)
- proteome (1)
- pulmonary embolism (1)
- pulsed-field (1)
- quark gluon plasma (1)
- radiotherapy (1)
- randomized (1)
- recurrence pattern (1)
- red blood cells (1)
- reference damage (1)
- registry for primary immunodeficiency (1)
- regorafenib (1)
- regorafenib csf concentration (1)
- renin-angiotensin system (1)
- repetition suppression (RS) (1)
- reproducibility (1)
- resource limitation (1)
- respiratory infections (1)
- retinoid X receptor (1)
- rhabdomyosarcoma (1)
- rhinovirus (1)
- rigor (1)
- risk factor progression (1)
- risk factors (1)
- risk of malignancy (1)
- s-process (1)
- sEH (1)
- scanning laser Doppler vibrometry (1)
- second-line (1)
- second-line immunotherapy (1)
- seizures (1)
- sequence alignment (1)
- sex (1)
- signal processing (1)
- simulation (1)
- simulation training (1)
- single nucleotide polymorphism (1)
- single subject classification (1)
- small molecule inhibitor (1)
- small molecules (1)
- social exclusion (1)
- social psychiatry (1)
- soft tissue sarcoma (1)
- solar physics (1)
- spectra (1)
- stability (1)
- stage II/III colorectal cancer (1)
- stakeholder (1)
- standardization (1)
- stearic acid (1)
- stereotactic radiosurgery (1)
- structural biology (1)
- structural health monitoring (1)
- subgrouping (1)
- surgery (1)
- synaesthesia (1)
- synchronization (1)
- synchrony (1)
- taller-than-wide (1)
- targeted axillary dissection (1)
- temozolomide (1)
- temporal classification (1)
- testis (1)
- tetracycline (1)
- theory of mind (1)
- therapeutic anticoagulation (1)
- therapy (1)
- therapy response (1)
- threats (1)
- thrombolysis (1)
- thrombolysis (tPA) (1)
- training (1)
- transfusion (1)
- transient elastography (1)
- trastuzumab (1)
- trauma (1)
- treatment resistance (1)
- tropical forests (1)
- tumor (1)
- tumor metabolism (1)
- tumor necrosis factor receptor superfamily member 9 (1)
- tumor-infiltrating lymphocytes (1)
- uncertainty (1)
- understudied kinase (1)
- uveal melanoma (1)
- valuation (1)
- vascular endothelial growth factor (1)
- vascular endothelial growth factor receptor (1)
- ventriculoperitoneal shunt (1)
- vessel-associated mural cells (1)
- visual priming (1)
- white and brown dwarfs (1)
- women (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1209)
- Frankfurt Institute for Advanced Studies (FIAS) (1005)
- Informatik (922)
- Medizin (225)
- Geowissenschaften (16)
- Biowissenschaften (13)
- Biochemie und Chemie (11)
- Senckenbergische Naturforschende Gesellschaft (8)
- Institut für Ökologie, Evolution und Diversität (6)
- Biochemie, Chemie und Pharmazie (5)
Azimuthal anisotropy measurement of (multi-)strange hadrons in Au+Au collisions at √sNN = 54.4 GeV
(2023)
Azimuthal anisotropy of produced particles is one of the most important observables used to access the collective properties of the expanding medium created in relativistic heavy-ion collisions. In this paper, we present second (v2) and third (v3) order azimuthal anisotropies of K0S, ϕ, Λ, Ξ and Ω at mid-rapidity (|y|<1) in Au+Au collisions at sNN−−−√ = 54.4 GeV measured by the STAR detector. The v2 and v3 are measured as a function of transverse momentum and centrality. Their energy dependence is also studied. v3 is found to be more sensitive to the change in the center-of-mass energy than v2. Scaling by constituent quark number is found to hold for v2 within 10%. This observation could be evidence for the development of partonic collectivity in 54.4 GeV Au+Au collisions. Differences in v2 and v3 between baryons and anti-baryons are presented, and ratios of v3/v3/22 are studied and motivated by hydrodynamical calculations. The ratio of v2 of ϕ mesons to that of anti-protons (v2(ϕ)/v2(p¯)) shows centrality dependence at low transverse momentum, presumably resulting from the larger effects from hadronic interactions on anti-proton v2.
We report results on an elastic cross section measurement in proton–proton collisions at a center-of-mass energy √𝑠 = 510 GeV, obtained with the Roman Pot setup of the STAR experiment at the Relativistic Heavy Ion Collider (RHIC). The elastic differential cross section is measured in the four-momentum transfer squared range 0.23 ≤ −𝑡 ≤ 0.67 GeV2. This is the only measurement of the proton-proton elastic cross section in this 𝑡 range for collision energies above the Intersecting Storage Rings (ISR) and below the Large Hadron Collider (LHC) colliders. We find that a constant slope 𝐵 does not fit the data in the aforementioned 𝑡 range, and we obtain a much better fit using a second-order polynomial for 𝐵(𝑡). This is the first measurement below the LHC energies for which the non-constant behavior 𝐵(𝑡) is observed. The 𝑡 dependence of 𝐵 is also determined using six subintervals of 𝑡 in the STAR measured 𝑡 range, and is in good agreement with the phenomenological models. The measured elastic differential cross section d𝜎∕dt agrees well with the results obtained at √𝑠 = 540 GeV for proton–antiproton collisions by the UA4 experiment. We also determine that the integrated elastic cross section within the STAR 𝑡-range is 𝜎f id el = 462.1 ± 0.9(stat.) ± 1.1(syst.) ± 11.6(scale) 𝜇b.
Mid-rapidity transverse mass spectra and multiplicity densities of charged and neutral kaons are reported for Au + Au collisions at √sNN = 130 GeV at RHIC. The spectra are exponential in transverse mass, with an inverse slope of about 280 MeV in central collisions. The multiplicity densities for these particles scale with the negative hadron pseudo-rapidity density. The charged kaon to pion ratios are K+/π− = 0.161± 0.002(stat) ± 0.024(syst) and K−/π− = 0.146± 0.002(stat) ± 0.022(syst) for the most central collisions. The K+/π− ratio is lower than the same ratio observed at the SPS while the K−/π− is higher than the SPS result. The ratios are enhanced by about 50% relative to p + p and p¯ + p collision data at similar energies.
We report results on an elastic cross section measurement in proton-proton collisions at a center-of-mass energy s√=510 GeV, obtained with the Roman Pot setup of the STAR experiment at the Relativistic Heavy Ion Collider (RHIC). The elastic differential cross section is measured in the four-momentum transfer squared range 0.23≤−t≤0.67 GeV2. We find that a constant slope B does not fit the data in the aforementioned t range, and we obtain a much better fit using a second-order polynomial for B(t). The t dependence of B is determined using six subintervals of t in the STAR measured t range, and is in good agreement with the phenomenological models. The measured elastic differential cross section dσ/dt agrees well with the results obtained at s√=546~GeV for proton--antiproton collisions by the UA4 experiment. We also determine that the integrated elastic cross section within the STAR t-range is σfidel=462.1±0.9(stat.)±1.1(syst.)±11.6(scale) μb.
Background: To study neoadjuvant chemoradiotherapy (nCRT) and potential predictive factors for response in locally advanced oral cavity cancer (LA-OCC).
Methods: The INVERT trial is an ongoing single-center, prospective phase 2, proof-of-principle trial. Operable patients with stage III-IVA squamous cell carcinomas of the oral cavity were eligible and received nCRT consisting of 60 Gy with concomitant cisplatin and 5-fluorouracil. Surgery was scheduled 6-8 weeks after completion of nCRT. Explorative, multiplex immunohistochemistry (IHC) was performed on pretreatment tumor specimen, and diffusion-weighted magnetic resonance imaging (DW-MRI) was conducted prior to, during nCRT (day 15), and before surgery to identify potential predictive biomarkers and imaging features. Primary endpoint was the pathological complete response (pCR) rate.
Results: Seventeen patients with stage IVA OCC were included in this interim analysis. All patients completed nCRT. One patient died from pneumonia 10 weeks after nCRT before surgery. Complete tumor resection (R0) was achieved in 16/17 patients, of whom 7 (41%, 95% CI: 18-67%) showed pCR. According to the Clavien-Dindo classification, grade 3a and 3b complications were found in 4 (25%) and 5 (31%) patients, respectively; grade 4-5 complications did not occur. Increased changes in the apparent diffusion coefficient signal intensities between MRI at day 15 of nCRT and before surgery were associated with better response (p=0.022). Higher abundances of programmed cell death protein 1 (PD1) positive cytotoxic T-cells (p=0.012), PD1+ macrophages (p=0.046), and cancer-associated fibroblasts (CAFs, p=0.036) were associated with incomplete response to nCRT.
Conclusion: nCRT for LA-OCC followed by radical surgery is feasible and shows high response rates. Larger patient cohorts from randomized trials are needed to further investigate nCRT and predictive biomarkers such as changes in DW-MRI signal intensities, tumor infiltrating immune cells, and CAFs.
This paper contains further applications on symmetrical liquid mixtures of the molecular thermodynamic theory which has been developped in part I of this series. The essential feature of this theory is the superposition of "chemical" and “random” exchange equilibria between “complexes” formed by a given molecule and its z nearest neighbours, thus allowing a unified treatment of the thermodynamic phenomena in binary liquid mixtures using the equilibrium constant K of the ideal law of mass action and the energy w of pair interactions as parameters.
The temperature and pressure dependences of K and the evaluation of experimental excess enthalpy and excess volume data are treated. Formulas and examples for the calculation of K and w from isothermal and non-isothermal vapour-liquid equilibrium data are given. The conditions for azeotropy with minimum or maximum vapour pressure, resp., are derived. Melting curves for a symmetric eutectic system with superposed miscibility gap are discussed. Further models for partially miscible liquids with competing self-association and complex-formation are treated showing the phenomenon of two separated miscibility gaps.
In this paper equilibrium models for the calculation of the excess Gibbs free energy of binary liquid mixtures are developed, the component A of which undergoes chain-forming self-association whilst the component B acts as an 'inert' solvent. It is shown that the extension of the well-known chain-association model of Mecke and Kempter, in which the probability of chain prolongation is assumed to be independent of chain length, is unable to establish satisfactory results because it does not exhibit sufficient unsymmetry. Reduction of the probability of chain growth with in-creasing chain length leads to an improved model with the geometric series replaced by the exponential series. This model, in which only two parameters are used, i. e. the equilibrium constants K for mutual solvation of A and B, and ρ for self-association of A, allows fitting of isothermal experimental GE /R T literature data on cycloalkanol-cycloalkane, alkanol-alkane, and NMF -CCl4 systems within the limits of experimental error. Compared with the two-parameter Wilson equation which gives equally small standard deviations, our equilibrium model has the advantage of allowing passage from GE to HE data and of being applicable to liquid-liquid equilibria.
Phasentrennung als Folge der Konkurrenz zwischen "statistischer" und "chemischer" Vermischung
(1977)
The fact that common thermodynamic conditions are valid for all known types of critical phases (liquid-liquid, liquid-gas, and "gas-gas") suggests that a common principle for the interpretation of material phase instability from a molecular point of view must exist. In this paper we show that the principle of competition between "statistical mixing" (i. e. random mixing) and "chemical mixing" (i. e. mixing effected under the influence of chemical interactions) can give this common inter pretation. If the equilibrium states resulting from both types of mixing are sufficiently different, phase separation occurs. We refer to our earlier papers (since 1972) in which we have applied this principle to describe liquid-liquid phase equilibria by "chemical" models, using the equilibrium constants of exchange equilibria between nearest-neighbour complexes as a measure of "chemical" mixing. In this paper we show that the well-known reduced gas-liquid coexistence curve, T/Tc =f(q/qc), can accurately be fitted by a very simple "mixture" model of molecules A with "vacan cies", provided that the contributions of both statistical and chemical mixing are incorporated into the formula for GE. From a discussion of the application to "gas-gas" phase equilibria in the hyper critical region it results that the weight factor r, by which the contribution of statistical mixing enters into GE, must depend on the density of the gas mixture. Phase separation can only occur if, by increasing pressure, the contributions to GE of statistical and chemical mixing have reached the same order of magnitude. From an attempt to apply the same principle to solid-liquid equilibria it is shown under which external conditions a critical point for this type of phase transition can be expected.
Cystic fibrosis (CF) lung disease is aggravated by recurrent and ultimately chronic bacterial infections. One of the key pathogens in adult CF lung disease is P. aeruginosa (PA). In addition to bacteria, respiratory viral infections are suggested to trigger pulmonary exacerbations in CF. To date, little is known on how chronic infections with PA influence susceptibility and response to viral infection. We investigated the interactions between PA, human rhinovirus (HRV) and the airway epithelium in a model of chronic PA infection using differentiated primary bronchial epithelial cells (pBECs) and clinical PA isolates obtained from the respiratory sample of a CF patient. Cells were repeatedly infected with either a mucoid or a non-mucoid PA isolate for 16 days to simulate chronic infection, and subsequently co-infected with HRV. Key cytokines and viral RNA were quantified by cytometric bead array, ELISA and qPCR. Proteolytic degradation of IL-6 was analyzed by Western Blots. Barrier function was assessed by permeability tests and transepithelial electric resistance measurements. Virus infection stimulated the production of inflammatory and antiviral mediators, including interleukin (IL)-6, CXCL-8, tumor necrosis factor (TNF)-α, and type I/III interferons. Co-infection with a non-mucoid PA isolate increased IL-1β protein concentrations (28.88 pg/ml vs. 6.10 pg/ml), but in contrast drastically diminished levels of IL-6 protein (53.17 pg/ml vs. 2301.33 pg/ml) compared to virus infection alone. Conditioned medium obtained from co-infections with a non-mucoid PA isolate and HRV was able to rapidly degrade recombinant IL-6 in a serine protease-dependent manner, whereas medium from individual infections or co-infections with a mucoid isolate had no such effect. After co-infection with HRV and the non-mucoid PA isolate, we detected lower mRNA levels of Forkhead box J1 (FOXJ1) and Cilia Apical Structure Protein (SNTN), markers of epithelial cell differentiation to ciliated cells. Moreover, epithelial permeability was increased and barrier function compromised compared to single infections. These data show that PA infection can influence the response of bronchial epithelial cells to viral infection. Altered innate immune responses and compromised epithelial barrier function may contribute to an aggravated course of viral infection in PA-infected airways.
Nuclear magnetic resonance measurements were carried out on neutron activated 20F(T1/2=11s) nuclei in a single crystal of KZnF3. The quadrupolar splitted NMR spectrum, detected via the 20F β-radiation asymmetry, could be observed using a radio frequency modulation technique. The quadrupole coupling constant was determined to e2 q Q/h= + (12.0 ± 1.5) MHz at room temperature. The sign of e2 q Q was obtained from a simultaneous γ-ray anisotropy measurement on the succeeding 20Ne transition. Utilising a calculated field gradient of the fluorine atom, an fQ = 4.6% is determined. This value is compared with literature data of similar compounds.